Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 15128 | 660 | 41.0 | 85% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | GENE THER Y S | Address | 12 | 37% | 4% | 25 |
| 2 | PATHOTROPIC TARGETING | Author keyword | 6 | 100% | 1% | 4 |
| 3 | RETROVIRAL ENTRY | Author keyword | 4 | 67% | 1% | 4 |
| 4 | ECOTROPIC MURINE LEUKEMIA VIRUS | Author keyword | 3 | 100% | 0% | 3 |
| 5 | SLC20A1 | Author keyword | 3 | 50% | 1% | 4 |
| 6 | SPLEEN NECROSIS VIRUS | Author keyword | 3 | 50% | 1% | 4 |
| 7 | RETROVIRAL RECEPTOR | Author keyword | 3 | 60% | 0% | 3 |
| 8 | INSERM U412 | Address | 2 | 23% | 1% | 9 |
| 9 | GIBBON APE LEUKEMIA VIRUS RECEPTOR | Author keyword | 2 | 67% | 0% | 2 |
| 10 | PL DIAGNOST | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PATHOTROPIC TARGETING | 6 | 100% | 1% | 4 | Search PATHOTROPIC+TARGETING | Search PATHOTROPIC+TARGETING |
| 2 | RETROVIRAL ENTRY | 4 | 67% | 1% | 4 | Search RETROVIRAL+ENTRY | Search RETROVIRAL+ENTRY |
| 3 | ECOTROPIC MURINE LEUKEMIA VIRUS | 3 | 100% | 0% | 3 | Search ECOTROPIC+MURINE+LEUKEMIA+VIRUS | Search ECOTROPIC+MURINE+LEUKEMIA+VIRUS |
| 4 | SLC20A1 | 3 | 50% | 1% | 4 | Search SLC20A1 | Search SLC20A1 |
| 5 | SPLEEN NECROSIS VIRUS | 3 | 50% | 1% | 4 | Search SPLEEN+NECROSIS+VIRUS | Search SPLEEN+NECROSIS+VIRUS |
| 6 | RETROVIRAL RECEPTOR | 3 | 60% | 0% | 3 | Search RETROVIRAL+RECEPTOR | Search RETROVIRAL+RECEPTOR |
| 7 | GIBBON APE LEUKEMIA VIRUS RECEPTOR | 2 | 67% | 0% | 2 | Search GIBBON+APE+LEUKEMIA+VIRUS+RECEPTOR | Search GIBBON+APE+LEUKEMIA+VIRUS+RECEPTOR |
| 8 | RETROVIRUS ENTRY | 2 | 67% | 0% | 2 | Search RETROVIRUS+ENTRY | Search RETROVIRUS+ENTRY |
| 9 | TARGETING VECTOR | 2 | 33% | 1% | 5 | Search TARGETING+VECTOR | Search TARGETING+VECTOR |
| 10 | MURINE LEUKEMIA VIRUS | 2 | 10% | 2% | 14 | Search MURINE+LEUKEMIA+VIRUS | Search MURINE+LEUKEMIA+VIRUS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | VIRUS DERIVED VIRUSES | 24 | 91% | 2% | 10 |
| 2 | RETROVIRUS RECEPTOR | 19 | 44% | 5% | 32 |
| 3 | RETROVIRAL TRANSMEMBRANE PROTEIN | 17 | 75% | 2% | 12 |
| 4 | ENVELOPE FUSION PROTEINS | 13 | 62% | 2% | 13 |
| 5 | ECOTROPIC ENVELOPE | 11 | 78% | 1% | 7 |
| 6 | GLVR1 | 8 | 100% | 1% | 5 |
| 7 | SARCOMA ASSOCIATED VIRUS | 8 | 100% | 1% | 5 |
| 8 | R PEPTIDE | 8 | 42% | 2% | 14 |
| 9 | CHAIN VARIABLE FRAGMENT | 7 | 36% | 2% | 15 |
| 10 | PATHOTROPIC NANOPARTICLES | 6 | 80% | 1% | 4 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Targeting retroviral and lentiviral vectors | 2003 | 67 | 158 | 61% |
| Retargeting gene delivery using surface-engineered retroviral vector particles | 2001 | 56 | 48 | 96% |
| Strategies for retargeted gene delivery using vectors derived from lentiviruses | 2004 | 33 | 183 | 51% |
| Replication-competent retrovirus vectors for cancer gene therapy | 2008 | 35 | 107 | 22% |
| Nanotechnology blooms, at last (Review) | 2005 | 17 | 10 | 70% |
| Targeting retrovirus entry | 1996 | 90 | 67 | 61% |
| Modifying the host range properties of retroviral vectors | 1999 | 52 | 92 | 77% |
| Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins | 2001 | 105 | 185 | 31% |
| Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status | 2013 | 43 | 115 | 10% |
| Cell surface receptors for gammaretroviruses | 2003 | 47 | 333 | 29% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GENE THER Y S | 12 | 37% | 3.8% | 25 |
| 2 | INSERM U412 | 2 | 23% | 1.4% | 9 |
| 3 | PL DIAGNOST | 2 | 67% | 0.3% | 2 |
| 4 | PREVENT THER EUT INFECT DIS | 2 | 67% | 0.3% | 2 |
| 5 | UMR 5535 IFR24 | 2 | 67% | 0.3% | 2 |
| 6 | VECTOROL RETROVIRALE THER IE GENIQUE | 2 | 40% | 0.6% | 4 |
| 7 | SECT MOL VIROL | 2 | 22% | 1.2% | 8 |
| 8 | LVRTG | 2 | 28% | 0.8% | 5 |
| 9 | MOL CELL SCI | 2 | 14% | 1.5% | 10 |
| 10 | RETROVIRAL BIOL | 1 | 23% | 0.5% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000237823 | RETROVIRAL VECTORS//RETROVIRAL VECTOR//SELECTIVE AMPLIFIER GENE |
| 2 | 0.0000195949 | PERSISTENT VIRAL DIS//FRIEND VIRUS//MOMULV TS1 |
| 3 | 0.0000131941 | XMRV//XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS//XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS XMRV |
| 4 | 0.0000124290 | LENTIVIRAL VECTOR//LENTIVIRAL VECTORS//EXPT HEMATOL |
| 5 | 0.0000100455 | VIRUS CELL INTERACT SECT//GAG//M PMV |
| 6 | 0.0000098714 | PORCINE ENDOGENOUS RETROVIRUSES//PERV//PORCINE CYTOMEGALOVIRUS |
| 7 | 0.0000095378 | AVIAN LEUKOSIS VIRUS//AVIAN LEUKOSIS VIRUS SUBGROUP J//MYELOID LEUKOSIS |
| 8 | 0.0000081452 | NA P I COTRANSPORT//PHOSPHATE TRANSPORT//NAPI IIA |
| 9 | 0.0000081277 | JAAGSIEKTE SHEEP RETROVIRUS//OVINE PULMONARY ADENOCARCINOMA//JAAGSIEKTE |
| 10 | 0.0000080354 | FELINE IMMUNODEFICIENCY VIRUS//FIV//FELINE LEUKEMIA VIRUS |